Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/emmGCfbwocfDsygxPUnR

March 6, 2013
Sign upForwardArchiveAdvertiseRead more at SmartBrief.com
News for nuclear medicine and molecular imaging professionals
 
The news summaries appearing in SNMMI SmartBrief are based on original information from multiple internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The items below are not selected or reviewed by SNMMI prior to publication. Questions and comments may be directed to SmartBrief at snmmi@smartbrief.com.

  Top Story 
  • Study finds decline in abnormal cardiac stress tests
    The rate of abnormal stress-rest SPECT-MPI tests has declined from 40.9% in 1991 to 8.7% in 2009, according to a study published in the Journal of the American College of Cardiology. The researchers also observed a similar trend concerning ischemic results and moderately to severely abnormal findings. The study reviewed data on 39,515 patients at Cedars-Sinai Medical Center in Los Angeles. The results "may be reflecting a broader temporal change toward milder clinical presentations of coronary artery disease (CAD)," according to the researchers. They said the report "suggests a need to refine the future diagnostic workup of patients with suspected CAD." MedPage Today (free registration) (3/5) LinkedInFacebookTwitterEmail this Story
  Clinical News & Research 
  • Researchers, vendors work to improve imaging of obese patients
    There are numerous challenges involved with molecular imaging of obese patients, including issues with radioisotope dosing and image acquisition and interpretation, according to Dr. Abdelhamid H. Elgazzar of Kuwait University. "It's crucial to take safety precautions and devise a strategy for preparation and interpretation of studies for this population," Elgazzar said. While researchers work to improve image quality, vendors are working to address logistical challenges with imaging cameras and tables that are more suited for such patients. MolecularImaging.net (3/4) LinkedInFacebookTwitterEmail this Story
  Industry Report 
  • Nordion: No decision on future plans
    Nordion has reported reduced quarterly losses owing to greater income tax recovery. Nordion, which has retained advisers to consider future options, said, "No decision has been made to enter into any specific strategic transaction or any other strategic alternative at this time." Reuters (3/5) LinkedInFacebookTwitterEmail this Story
  News from the Field 
  Health Policy 
  • White House to Congress: Exempt FDA user fees from sequester
    The Obama administration urged Congress to allow the FDA to spend $41 billion in drugmaker user fees. The sequestration law limits the amount of fee-derived funds that the agency can spend, and experts warn that the agency will not be able to approve new drug and device applications quickly if the funds are subject to sequestration. Sequestration will slow progress toward cures and cost thousands of researchers their jobs, the White House warned. PharmaTimes (U.K.) (3/5) , The Philadelphia Inquirer (2/28) LinkedInFacebookTwitterEmail this Story
  Advancing Health Care 
  ADVERTISEMENT  
  From SNMMI 
SNMMI  |  News  |  Meetings  |  Education  |  Publications  |  Membership

SNMMI on Facebook  |  SNMMI on LinkedIn  |  SNMMI on Twitter  |  SNMMI on YouTube

  SmartQuote 
Every time you spend money, you're casting a vote for the kind of world you want."
--Anna Lappé,
American writer, speaker and activist


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
   
Print friendly format  | Web version  | Search past news  | Archive  | Privacy policy

Advertise
Account Director:   Meryl Harold   (202) 407-7828
 
Read more at SmartBrief.com
 
 
 Recent SNMMI SmartBrief Issues:   Lead Editor:   Melissa Turner
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.®  Legal Information